PAG
BSTC

Private Advisor Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Private Advisor Group’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-887
Closed -$54K – 3876
2020
Q2 		$54K Buy
+887
New +$51.3K ﹤0.01% 2067

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Private Advisor Group's BSTC Position: Q3 2020 in Review

Private Advisor Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 887 shares — an estimated $54K sold.

Private Advisor Group first reported a position in BSTC in Q2 2020 and held it in 1 quarter. The position peaked at $54K in Q2 2020. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

  • Private Advisor Group reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 887 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $54K.
  • Private Advisor Group first reported a position in BioSpecifics Technologies Corp. in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's BioSpecifics Technologies Corp. position peaked at $54K in Q2 2020.
  • 113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.